Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Rodney B Luwor |
| Publication date | March 15, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |